A bioeconomical miracle: how India has increased the industry 16 times in 10 years

A bioeconomical miracle: how India has increased the industry 16 times in 10 years
Most Popular
08.02
Ozon logistics is becoming more expensive, clusters are splitting up: how to plan deliveries and not burn margins on SVD
07.02
Sales on the WB dropped after the holidays: how to return positions without draining the betting budget
06.02
Starting from July 1, cargo from the EAEU will not travel without a QR code: lawyers advise to fix the code in the contract as a condition of departure
06.02
How to legally change the payer or recipient and not get stuck on bank compliance
06.02
Marketplaces can "assign" tariffs: the point of no return is control of a third of the transportation market
06.02
Wildberries is preparing a pilot in Ethiopia and is eyeing India: why does the marketplace need a "far abroad"
India's bioeconomy has grown from $10 billion to $165 billion in 10 years. The country has become a leader in vaccine production and has reached 20% ethanol content in gasoline ahead of schedule.

India is making impressive strides in developing the bioeconomy, showing one of the fastest growth rates in the world over the past decade. According to the international agency IANS, the volume of this strategically important sector has increased more than sixteen times, from a modest $10 billion in 2014 to an impressive $165.7 billion in 2024.

Bioeconomics based on the use of renewable biological resources has become a key driver of Indian economic development. The current structure of the sector is characterized by the predominance of industrial production and the pharmaceutical industry, while agricultural technologies and scientific research occupy a slightly smaller but strategically important share.

India has achieved particular success in the pharmaceutical sector. Already in 2025, the country has consolidated its position as a world leader in the production of vaccines, significantly increasing both domestic production and export of medical products. This achievement is of particular importance in the context of the global need for affordable and high-quality biotechnological products.

One of the most significant breakthroughs was the energy program. India managed to reach the 20% ethanol content target in gasoline ahead of schedule, five years ahead of schedule. For comparison, in 2014 this figure was only 1.5%, which demonstrates tremendous progress in the field of renewable energy sources.

The ethanol production program has brought tangible benefits to Indian farmers. Over the years of the project, agricultural producers have received about $182.9 billion for the supply of raw materials for the production of biofuels. This significantly increased the profitability of the agricultural sector and contributed to the development of rural regions of the country.

The Indian government has no plans to stop there. An ambitious goal has already been set to bring the volume of the bioeconomy to $300 billion by 2030. This growth implies the further development of biotechnologies, the improvement of agricultural practices, the expansion of bio-production and the strengthening of positions in the healthcare sector.

India's success in developing the bioeconomy is becoming an important example for other emerging economies, demonstrating how sound government policies and investments in innovative biotechnologies can contribute to sustainable economic growth and improve the quality of life of the population.